Clinical Cancer Drugs
Title:Meet Our Editor-in-Chief
Volume: 4
Author(s): Giulio Francia*
Affiliation:
- The University of Texas El Paso, TX,United States
Export Options
About this article
Cite this article as:
Francia Giulio*, Meet Our Editor-in-Chief, Clinical Cancer Drugs 2017; 4 (1) . https://dx.doi.org/10.2174/2212697X0401170526184110
DOI https://dx.doi.org/10.2174/2212697X0401170526184110 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lectins in Human Cancer: Both a Devil and an Angel?
Current Protein & Peptide Science Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Biocatalyzed On Water Synthesis of Chiral Building Blocks for the Preparation of Anti-Cancer Drugs: a GreenerApproach
Current Organic Chemistry Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Current Enzyme Inhibition Potential New Anticancer Molecular Targets for the Treatment of Human Testicular Seminomas
Mini-Reviews in Medicinal Chemistry Microwave Assisted Synthetic Approach of New Pyridine based Benzothiazepines: Their Antibacterial and Antifungal Activities
Current Microwave Chemistry Development of a Sensitive Cost-Effective Capture ELISA for Detection of Murine Monoclonal Antibodies - Correlation with SPR Biosensor Technology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy
Current Topics in Medicinal Chemistry Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways
Current Diabetes Reviews Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy
Current Medicinal Chemistry The PARAMOUNT Trial: A Phase III Randomized Study of Maintenance Pemetrexed Versus Placebo Immediately Following Induction First-line Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials The Immunoproteasome as a Therapeutic Target for Hematological Malignancies
Current Cancer Drug Targets Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Current Molecular Medicine Determination of Mutation Pattern in Human Androgen Receptor by Means of Amino-Acid Pair Predictability
Protein & Peptide Letters Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis
Current Vascular Pharmacology Carbonyl-Scavenging Drugs & Protection Against Carbonyl Stress-Associated Cell Injury
Mini-Reviews in Medicinal Chemistry Natural Compounds in the Chemoprevention of Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Notch Signaling in Mammalian Intestinal Stem Cells: Determining Cell Fate and Maintaining Homeostasis
Current Stem Cell Research & Therapy